A federal judge has declared a mistrial in the first trial to be held over whether Fosamax, Merck & Co.’s osteoporosis drug, causes painful jaw bone destruction after it became evident that jurors in the month-long trial in New York were deadlocked. Judge John F. Keenan declared a mistrial in the case brought by Plaintiff Shirley Boles. The Plaintiff, a 71-year-old Florida woman, developed severe dental and jaw-related problems several years after she began taking Fosamax in 1997.

Source: Forbes

Other Related Articles

• Merck Hit With $8 Million Verdict In Fosamax Trial
• Jury Rules For The Defendant In Second Fosamax Trial
• Merck faces first Fosamax trial
• Plaintiff Can Show Causation in Fosamax Case
• Montgomery Fosamax trial will be one of the first in the nation